SEP
BSX icon

Southland Equity Partners’s Boston Scientific BSX Stock Holding History

Southland Equity Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,664
Closed -$254K – 274
2025
Q4 		$254K Buy
2,664
+320
+14% +$31.4K 0.05% 217
2025
Q3 		$229K Buy
2,344
+210
+10% +$21.7K 0.05% 220
2025
Q2 		$229K Sell
2,134
-45
-2% -$4.55K 0.05% 214
2025
Q1 		$220K Buy
+2,179
New +$219K 0.05% 213

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Southland Equity Partners's BSX Position: Q1 2026 in Review

Southland Equity Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,664 shares — an estimated $254K sold.

Southland Equity Partners first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $254K in Q4 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Southland Equity Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Southland Equity Partners sold 2,664 Boston Scientific shares in Q1 2026, an estimated $254K.
  • Southland Equity Partners first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
  • Southland Equity Partners's Boston Scientific position peaked at $254K in Q4 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Southland Equity Partners's 13F filing for Q1 2026, filed 14 Apr 2026.